MENU
MREO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mereo BioPharma Group (MREO) Earnings Date & Reports

A.I. Advisor
published Earnings

MREO is expected to report earnings to fall 150.00% to 0 cents per share on March 26

Mereo BioPharma Group MREO Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Est.
$-0.02
Q2'24
Missed
by $0.01
Q4'23
Est.
$-0.02
Q2'23
Est.
$-0.02
The last earnings report on November 12 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 1.48M shares outstanding, the current market capitalization sits at 591.10M.
View a ticker or compare two or three
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com